Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Both genetic and lifestyle factors significantly affect female hair loss.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Most Sudanese married women in the study used contraceptives and knew about them, but many didn't know about emergency contraceptives or extra benefits beyond family planning.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.